Lawrence Kaufman
President and CEO at X1 Biotech.
Earliest Form D on file: Jun 2026
Filed Jun 15, 2026
X1 Biotech
RUNX1 inhibitor for inherited small-vessel brain disease
Biotech, Needham MA
Signed as President and CEO
Network
At X1 Biotech
5 peopleDirector
Director
Director
Executive Officer
Director